Title: The progress of inhaled corticosteroid/long-acting β_2-agonist combinations in the treatment of asthma
Abstract: Inhaled corticosteroid/long-acting β2-agonist(ICS/LABA) combinations play synergic and complementary roles in controlling airway inflammation and improving the function of airway smooth muscle. They are very important drugs for asthma maintenance. The different combinations of ICS/LABA, such as fluticasone propionate/salmeterol, budesonide/formoterol, beclomethasones dipropionate/formoterol, mometasone furoate/formoterol, have different pharmacological features. This review summarizes the features and progress of these ICS/LABA in the treatment of asthma.
Publication Year: 2014
Publication Date: 2014-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot